谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-Term Safety, Efficacy, and Adherence of Tralokinumab for the Treatment of Patients with moderate to severe atopic Dermatitis over a Period of up to 3 Years: Interim Analysis of ECZTEND, a Phase III Long-Term Extension Study

Andreas Wollenberg,Andrew Blauvelt,Jean-Philippe Lacour,Darryl Toth,Vivian Laquer,Pedro Herranz,Andrew Pink,Ketty Peris,Hidehisa Saeki,Stefan Beissert

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT（2022）

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要